iShares Core FTSE 100 UCITS ETF (LON:ISFD)
London · Delayed Price · Currency is GBP · Price in USD | Assets | 172.69M |
| Expense Ratio | 0.20% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +22.09% |
| Volume | 28,089 |
| Open | 9.98 |
| Previous Close | 10.06 |
| Day's Range | 9.96 - 10.07 |
| 52-Week Low | 8.18 |
| 52-Week High | 10.42 |
| Beta | 0.94 |
| Holdings | 110 |
| Inception Date | Oct 19, 2017 |
About ISFD
iShares Core FTSE 100 UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the FTSE 100 Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as iShares Core FTSE 100 UCITS ETF (Dist). iShares Core FTSE 100 UCITS ETF was formed on April 27, 2000 and is domiciled in Ireland.
Performance
ISFD had a total return of 22.09% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.39%.
Top 10 Holdings
48.62% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC Holdings plc | HSBA | 9.86% |
| AstraZeneca PLC | AZN | 7.85% |
| Shell plc | SHEL | 6.71% |
| Rolls-Royce Holdings plc | RR | 4.76% |
| Unilever PLC | ULVR | 3.76% |
| British American Tobacco p.l.c. | BATS | 3.69% |
| Rio Tinto Group | RIO | 3.12% |
| BP p.l.c. | BP | 3.06% |
| GSK plc | GSK | 3.06% |
| Barclays PLC | BARC | 2.77% |